VAN NOSTRAND ROBERT L

CIK 00012251987 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001225198

Recent Transactions

50 trades

Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2026-01-07+50,000→ 82,900 total
Purchase
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2025-06-12$1.48/sh+10,000→ 20,400 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−20,000→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−2,951→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−20,000→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−4,322→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−7,009→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−20,000→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−16,757→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−11,340→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−20,000→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−20,000→ 0 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2025-01-10+12,500→ 22,900 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2025-01-10+18,500→ 18,500 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-06-28$68.49/sh+83→ 11,340 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-06-23−1,567→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-06-23+1,567→ 11,257 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-06-18$75.71/sh−8,891→ 20,799 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-06-18$76.07/sh−11,109→ 9,690 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-06-18$16.86/sh+20,000→ 29,690 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-06-18−20,000→ 0 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-06-14+2,951→ 2,951 total
Award
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-06-14+4,322→ 4,322 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-31$69.20/sh+79→ 9,690 total
Award
YIELD10 BIOSCIENCE, INC.
Common Stock
2024-03-28+11,924→ 48,635 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-27$73.14/sh−10,349→ 9,611 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-27$18.56/sh+20,000→ 29,611 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-02-27−20,000→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-27$72.71/sh−9,651→ 19,960 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2024-01-22+6,000→ 10,400 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2024-01-22+10,000→ 10,000 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2023-12-31$71.62/sh+76→ 9,611 total
Award
YIELD10 BIOSCIENCE, INC.
Common Stock
2023-12-29+18,879→ 36,711 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2023-09-30$52.09/sh+105→ 9,535 total
Award
YIELD10 BIOSCIENCE, INC.
Common Stock
2023-09-29+13,868→ 17,832 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-30$63.32/sh+85→ 9,430 total
Award
YIELD10 BIOSCIENCE, INC.
Common Stock
2023-06-30+2,040→ 3,964 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2023-06-23+1,567→ 1,567 total
Award
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2023-06-23+7,009→ 7,009 total
Award
YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
2023-05-25+5,000→ 5,000 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-04-17$63.00/sh−10,000→ 9,345 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-04-17$13.05/sh+10,000→ 19,345 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2023-04-17−10,000→ 0 total
Award
YIELD10 BIOSCIENCE, INC.
Common Stock
2023-03-31+1,642→ 1,924 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-31$54.15/sh+95→ 9,345 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2023-02-02+2,500→ 4,400 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2023-02-02+9,500→ 9,500 total
Award
YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
2022-12-31$1.58/sh+2,109→ 2,109 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2022-12-30$52.92/sh+97→ 9,250 total
Award
YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
2022-09-30$2.83/sh+1,601→ 1,601 total

Companies

Recent Filings

Address

C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503

NEW YORK, NY, 10036

View on SEC.gov